麻疹-德國麻疹疫苗市場：依疫苗品牌、通路和地區分類

MR Vaccines Market, By Vaccine Brand (MR Vaccine, MRBEV (BE LTD.)), By Distribution Channel (Public, Private), By Geography (Commonwealth of Independent States (CIS) Countries, Latin America, Europe, Asia Pacific, Middle East, Africa)

出版日期: 2026年03月05日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年麻疹-德國麻疹疫苗市場規模估計為7,200萬美元，預計2033年將達到1.016億美元。預計2026年至2033年，該市場將以2.1%的複合年成長率成長。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	7200萬美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	2.10%	預計金額（2033 年）	1.016億美元

麻疹-德國麻疹疫苗（MR疫苗）是活病毒疫苗，可預防麻疹和德國麻疹病毒感染。該疫苗透過刺激人體產生抗病毒防禦機制（抗體）發揮作用。麻疹（也稱為咳嗽麻疹、嚴重麻疹、麻疹樣皮疹、紅麻疹、德國麻疹和十日麻疹）是一種傳染性極強的感染疾病。麻疹感染可導致嚴重的併發症，包括肺炎、中耳炎、鼻竇炎、癲癇、腦損傷甚至死亡。成人和5歲以下兒童發生嚴重併發症和死亡的風險更高。如果孕婦感染德國麻疹（也稱為德國麻疹），可能導致流產、死產或胎兒出生缺陷。

市場動態

麻疹-德國德國麻疹(MR) 疫苗是一種皮下注射疫苗，用於為易感人群（包括青少年、青少年、兒童和嬰兒）提供針對麻疹和德國麻疹的主動免疫。麻疹和德國德國麻疹(MR) 發病率的上升、MR 疫苗研發的臨床試驗正在進行、人們對免疫服務的認知不斷提高、政府主導的疫苗接種運動宣傳活動日益增多，以及非內部成長策略的日益普及（例如 MR 疫苗市場主要企業與世界衛生組織 (WHO)、聯合國兒童基金會 (UNICEF) 和全球疫苗接種全球疫苗免疫聯盟)免疫聯盟階段的合作期間

例如，據世界衛生組織（世衛組織）稱，2020 年 1 月至 2021 年 4 月期間，非洲 8 個國家爆發了大規模麻疹疫情，由於免疫接種計劃的延誤和常規疫苗接種率低，導致數萬名兒童受到影響。

本報告的主要特點

本報告指出了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本文根據以下參數，介紹了全球麻疹-德國麻疹疫苗市場主要企業的概況：公司概況、產品系列、主要亮點、財務績效和策略。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
《全球麻疹-德國麻疹疫苗市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球麻疹-德國麻疹疫苗市場中使用的各種策略矩陣來促進決策。

獨立國協（獨立國協）
- 俄羅斯
- 烏茲別克
- 哈薩克
- 烏克蘭
- 土庫曼
- 白俄羅斯
- 亞美尼亞
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 宏都拉斯
- 哥倫比亞
- 秘魯
- 智利
歐洲
- 土耳其
- 亞洲
- 巴基斯坦
- 印尼
- 孟加拉
- 菲律賓
- 越南
- 泰國
- 緬甸
- 馬來西亞
- 柬埔寨
- 尼泊爾
- 斯里蘭卡
- 巴布亞紐幾內亞
- 模里西斯
中東
- 阿拉伯聯合大公國
- 以色列
- 伊拉克
- 伊朗
- 沙烏地阿拉伯
- 約旦
- 卡達
- 阿曼
- 阿拉伯敘利亞共和國
非洲
奈及利亞
坦尚尼亞
剛果民主共和國
衣索比亞
肯亞
南非
埃及
摩洛哥
迦納
烏干達
布吉納法索
安哥拉
阿爾及利亞
辛巴威
突尼西亞
波札那
利比亞
奈米比亞

第7章競爭情勢

熱圖分析
市佔率分析
- PT Bio Farma
- Bio-Manguinhos
- Crucell Switzerland AG
- Serum Institute of India
- BE Vaccines

第8章

參考
分析方法

簡介目錄

Product Code: CMI4917

MR Vaccines Market is estimated to be valued at USD 72.0 Mn in 2026 and is expected to reach USD 101.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 2.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 72.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	2.10%	2033 Value Projection:	USD 101.6 Mn

Measles and rubella is a live virus vaccine that protects against infection with the measles and rubella viruses. It works by causing the body to produce its antiviral defenses (antibodies). Measles (also known as coughing measles, hard measles, morbilli, red measles, rubeola, and 10-day measles) is a highly contagious infectious disease. Measles infection can result in significant complications such as pneumonia, ear infections, sinus infections, convulsions (seizures), brain damage, and death. Adults and children under the age of 5 years are at a higher risk of serious complications and mortality. When pregnant women contract rubella (also known as German measles), it can result in miscarriages, stillbirths, or birth abnormalities in their unborn children.

Market Dynamics

Measles and Rubella (MR) vaccine is a subcutaneous injection for active immunization against Measles and Rubella in young adults, adolescents, children, and infants at risk. Increasing incidence of Measles and Rubella (MR), ongoing clinical trials to develop MR vaccines, growing awareness about immunization services, rising government initiatives to launch vaccine campaigns, and increasing adoption of inorganic growth strategies such partnerships by key players operating in the MR vaccines market with organizations such as WHO, UNICEF, and the GAVI Alliance are the major factors that are expected to drive growth of the MR vaccines market over the forecast period.

For instance, according to the World Health Organization (WHO), from January 2020 to April 2021, eight African nations experienced major measles outbreaks that affected tens of thousands of children, owing to delayed vaccination programs or low routine immunization coverage.

Key features of the study

This report provides an in-depth analysis of the MR vaccines market, and provides market size (US$ Mn. and No. of Doses in Mn.), and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the MR vaccines market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include PT Bio Farma, Bio-Manguinhos, BE Vaccines, Serum Institute of India, and Crucell Switzerland AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The MR vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the MR vaccines market

Market Segmentation

By Vaccine Brand
- MR Vaccine
- MRBEV (BE LTD.)
By Distribution Channel
- Public
- Private
By Region
- Commonwealth of Independent States (CIS) Countries
- Russia
- Uzbekistan
- Kazakhstan
- Ukraine
- Turkmenistan
- Belarus
- Armenia
- Latin America
- Brazil
- Argentina
- Mexico
- Honduras
- Colombia
- Peru
- Chile
- Europe
- Turkey
- Asia Pacific
- Pakistan
- Indonesia
- Bangladesh
- Philippines
- Vietnam
- Thailand
- Myanmar
- Malaysia
- Cambodia
- Nepal
- Sri Lanka
- Papua New Guinea
- Mauritius
- Middle East
- Israel
- UAE
- Iraq
- Iran
- Saudi Arabia
- Jordan
- Qatar
- Oman
- Syrian Arab Republic
- Africa
- South Africa
- Nigeria
- Tanzania
- Democratic Republic of Congo
- Ethiopia
- Kenya
- Egypt
- Morocco
- Ghana
- Uganda
- Burkina Faso
- Angola
- Algeria
- Zimbabwe
- Tunisia
- Botswana
- Libya
- Namibia
Key Players
- PT Bio Farma
- Bio-Manguinhos
- BE Vaccines
- Serum Institute of India
- Crucell Switzerland AG

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Vaccine Brand
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
  - Therapy Assessment
  - Disease Assessment
  - Epidemiological Assessment
  - Industry Assessment

4. MR Vaccines Market, By Vaccine Brand, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
MR Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
MRBEV (BE LTD.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. MR Vaccines Market, By Distribution Channel, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. MR Vaccines Market, By Region, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
Commonwealth of Independent States (CIS) Countries
- Market Size and Forecast, By Vaccine Brand, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Russia
  - Uzbekistan
  - Kazakhstan
  - Ukraine
  - Turkmenistan
  - Belarus
  - Armenia
Latin America
- Market Size and Forecast, By Vaccine Brand, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Honduras
  - Colombia
  - Peru
  - Chile
Europe
- Market Size and Forecast, By Vaccine Brand, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Turkey
  - Asia
- Market Size and Forecast, By Vaccine Brand, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Pakistan
  - Indonesia
  - Bangladesh
  - Philippines
  - Vietnam
  - Thailand
  - Myanmar
  - Malaysia
  - Cambodia
  - Nepal
  - Sri Lanka
  - Papua New Guinea
  - Mauritius
Middle East
- Market Size and Forecast, By Vaccine Brand, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - UAE
  - Israel
  - Iraq
  - Iran
  - Saudi Arabia
  - Jordan
  - Qatar
  - Oman
  - Syrian Arab Republic
Africa
- Market Size and Forecast, By Vaccine Brand, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Region/Country, 2026 - 2033, (USD Mn)
Nigeria
Tanzania
Democratic Republic of Congo
Ethiopia
Kenya
South Africa
Egypt
Morocco
Ghana
Uganda
Burkina Faso
Angola
Algeria
Zimbabwe
Tunisia
Botswana
Libya
Namibia

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- PT Bio Farma
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Bio-Manguinhos
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Crucell Switzerland AG
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Serum Institute of India
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- BE Vaccines
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
  - Analyst Views